Health Canada issues draft guidelines on follow-on biologics

03/24/2008 | FDAnews

Health Canada has issued preliminary guidance for companies seeking approval for "subsequent-entry biologics," the government's first step toward allowing the sale of follow-on versions of biotech drugs. The agency, which plans to publish more guidelines for specific biologic product classes, says existing laws authorize it to clear subsequent-entry products until legislation creates a new approval path.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
Actuary
NTA Life
Addison, TX
Vice President - Government Products
Health Alliance Plan
Detroit, MI